Literature DB >> 9470911

Genetic counselling in psoriasis: empirical data on psoriasis among first-degree relatives of 3095 psoriatic probands.

G Swanbeck1, A Inerot, T Martinsson, C Enerbäck, F Enlund, L Samuelsson, M Yhr, J Wahlström.   

Abstract

The risk of getting psoriasis dependent on the occurrence of psoriasis in the family has been determined empirically. Altogether 3717 families with one or both parents who had psoriasis have been analysed with regard to the number of children with or without psoriasis. The lifetime risk of getting psoriasis if no parent, one parent or both parents have psoriasis is 0.04, 0.28 and 0.65, respectively. If there is already one affected child in the family, the corresponding risks are 0.24, 0.51 and 0.83, respectively. The risk of getting psoriasis before the age of 32 years is dependent on the age-of-onset of psoriasis in one affected parent.

Entities:  

Mesh:

Year:  1997        PMID: 9470911

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  [Genetics of common chronic inflammatory skin diseases : An update on atopic dermatitis and psoriasis].

Authors:  E Rodríguez; K Eyerich; S Weidinger
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 2.  Genetic factors in psoriatic arthritis.

Authors:  Eleanor Korendowych; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 3.  Management of psoriasis in pregnancy.

Authors:  Sophie Weatherhead; Stephen C Robson; Nick J Reynolds
Journal:  BMJ       Date:  2007-06-09

Review 4.  Genetic epidemiology of psoriasis and psoriatic arthritis.

Authors:  P Rahman; J T Elder
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

5.  Genetic background of psoriasis.

Authors:  Hani A Alshobaili; Muhammad Shahzad; Abdullah Al-Marshood; Alsayed Khalil; Ahmad Settin; Issam Barrimah
Journal:  Int J Health Sci (Qassim)       Date:  2010-01

Review 6.  The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients.

Authors:  Ulrich Mrowietz; James T Elder; Jonathan Barker
Journal:  Arch Dermatol Res       Date:  2006-10-05       Impact factor: 3.017

7.  Infliximab (Remicade) in the treatment of psoriatic arthritis.

Authors:  Philip Mease
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

8.  Cohort profile: the clinical 'Psoriasis in Adolescents' (PIA) cohort in Denmark.

Authors:  Christoffer Blegvad; Anne-Marie Nybo Andersen; Jonathan Groot; Claus Zachariae; Lone Skov
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.